Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease

被引:3
|
作者
Mitchell, Jonathan [1 ]
Herrick-Reynolds, Kayleigh [2 ]
Motter, Jennifer D. [1 ]
Teles, Mayan [1 ]
Kates, Olivia [3 ]
Sung, Hannah [1 ]
Chen, Po-Hung [3 ]
King, Elizabeth [1 ]
Cameron, Andrew [1 ,4 ]
机构
[1] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD USA
[2] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Dept Surg, 720 Rutland Ave, Ross 765, Baltimore, MD 21205 USA
来源
TRANSPLANTATION DIRECT | 2023年 / 9卷 / 09期
基金
美国国家卫生研究院;
关键词
FOLLOW-UP; PREDICTORS; ABSTINENCE; RELAPSE;
D O I
10.1097/TXD.0000000000001532
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Many centers have removed 6-mo pretransplant alcohol abstinence requirements to provide early liver transplant (ELT) for individuals with severe alcohol-associated liver disease (ALD), but the practice remains controversial. Using data collected from a nationally distributed survey, this study examines the practices and attitudes of transplant centers in the United States regarding ELT. Methods. A 20-item survey designed to assess center practices and provider attitudes was distributed to 225 medical and surgical directors from 143 liver transplant centers via email. Results. Surveys were completed by 28.9% (n = 65) of directors and 39% (n = 56) of transplant centers. All responding centers reported evaluating patients for ELT. Circumstances for considering ELT included <6 mo of survival without a transplant (96.4%) and inability to participate in alcohol addiction therapy pretransplant (75%). Most (66%) directors indicated their center had established criteria for listing candidates with severe ALD for ELT. Regarding important factors for ELT candidate listing, 57.1% indicated patient survival, 37.5% indicated graft survival, and 55.4% indicated having a low risk of relapse. Only 12.7% of directors affirmed the statement, "Six months of pretransplant abstinence decreases the risk of relapse."Conclusions. More centers are providing ELT for severe ALD. Inability to participate in alcohol addiction therapy and <6 mo of survival are commonly reported circumstances for considering ELT. Continued investigation of posttransplant outcomes in patients receiving ELT is essential to establishing a national consensus for distributing this valuable resource.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Pathogenesis of Alcohol-Associated Liver Disease*
    Osna, Natalia A.
    Rasineni, Karuna
    Ganesan, Murali
    Donohue, Terrence M.
    Kharbanda, Kusum K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (06) : 1492 - 1513
  • [42] INCREASING TRENDS ON ALCOHOL-ASSOCIATED LIVER DISEASE AND METABOLIC-ASSOCIATED STEATOHEPATITIS IN SPECIFIC CANDIDATE GROUPS AMONG LIVER TRANSPLANT LISTINGS
    Jalil, Sajid
    Panneerselvam, Deepan
    Elfeki, Mohamed A.
    Dunn, Winston
    Wong, Robert
    Kulkarni, Anand V.
    Singal, Ashwani K.
    GASTROENTEROLOGY, 2024, 166 (05) : S1687 - S1688
  • [43] Epidemiology of Alcohol-Associated Liver Disease
    Han, Sen
    Yang, Zhihong
    Zhang, Ting
    Ma, Jing
    Chandler, Kristina
    Liangpunsakul, Suthat
    CLINICS IN LIVER DISEASE, 2021, 25 (03) : 483 - 492
  • [44] POOR DENTITION IS ASSOCIATED WITH POOR POST-TRANSPLANT SURVIVAL AMONG ALCOHOL-ASSOCIATED LIVER DISEASE PATIENTS
    Sempokuya, Tomoki
    Twohig, Patrick
    Merani, Shaheed
    Khoury, Nathalie
    HEPATOLOGY, 2023, 78 : S337 - S338
  • [45] Risk of alcohol-associated liver disease in the offspring of parents with alcohol-associated liver disease: A nationwide cohort study
    Jepsen, Peter
    West, Joe
    Kann, Anna Emilie
    Kraglund, Frederik
    Morling, Joanne
    Crooks, Colin
    Askgaard, Gro
    HEPATOLOGY, 2024, 80 (02) : 418 - 427
  • [46] OUTCOMES OF LIVER TRANSPLANTION IN SEVERE ACUTE ALCOHOLICASSOCIATED HEPATITIS AND ALCOHOL-ASSOCIATED CIRRHOSIS AT THE UNIVERSITY OF UTAH TRANSPLANT CENTER
    McDaniel, Charles W.
    Ofori-Atta, Blessing
    Kim, Rebecca G.
    Gallegos-Orozco, Juan F.
    GASTROENTEROLOGY, 2024, 166 (05) : S1750 - S1750
  • [47] UTILITY OF SUSTAINED ALCOHOL USE AFTER LIVER TRANSPLANTATION (SALT) SCORE TO PREDICT GRAFT SURVIVAL IN LIVER TRANSPLANT RECIPIENTS FOR ALCOHOL-ASSOCIATED LIVER DISEASE.
    Abdul, Mubeen Khan Mohammed
    Begum, Rehana
    Besur, Siddesh
    Garcia, Moises Antonio
    Pedersen, Rachel
    Jain, Gaurav
    Sahajpal, Ajay
    HEPATOLOGY, 2021, 74 : 913A - 913A
  • [48] IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON WAITLIST MORTALITY AND RECEIVING A LIVER TRANSPLANT AMONG PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE.
    Patel, Arsheya
    Jalil, Sajid
    Kuo, Yong-Fang
    Chandra, San
    Mumtaz, Khalid
    Singal, Ashwani K.
    HEPATOLOGY, 2022, 76 : S130 - S131
  • [49] POST-TRANSPLANT OUTCOMES FOR ALCOHOL-ASSOCIATED LIVER DISEASE DURING THE COVID-19 PANDEMIC
    Goli, Karthik
    Lymberopoulos, Peter
    Shaikh, Anjiya
    Parakadavil, Nisha
    Kim, Donghee
    Ahmed, Aijaz
    Goss, John A.
    Rana, Abbas
    Lee, Tzu-Hao
    Kanwal, Fasiha
    Cholankeril, George
    HEPATOLOGY, 2022, 76 : S532 - S533
  • [50] PROTOCOLIZED ALCOHOL BIOMARKER SCREENING DETECTS EQUIVALENT RATES OF RECENT DRINKING IN HCC AND ALCOHOL-ASSOCIATED LIVER DISEASE PATIENTS EVALUATED FOR LIVER TRANSPLANT
    Bowman-Zamora, Chip
    Nahas, Jonathan
    Im, Gene Y.
    HEPATOLOGY, 2021, 74 : 901A - 902A